High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma

J Chromatogr B Biomed Sci Appl. 2001 Nov 5;763(1-2):173-83. doi: 10.1016/s0378-4347(01)00391-7.

Abstract

A selective HPLC assay is described for the determination of free and total (free plus polymer-bound) camptothecin (CPT) in human plasma after administration of the anti-tumor drug MAG-CPT (polymer bound camptothecin). Total CPT levels were determined after hydrolysis and free CPT was extracted from acidified plasma using Oasis solid-phase extraction material. Extracts were analyzed on a Zorbax SB-C8 analytical column, using a mixture of acetonitrile-25 mM phosphate buffer (pH 4.0) as the eluent. Detection was performed fluorimetrically. Concentrations of polymer-bound CPT were calculated by subtraction of free from total CPT. The lower limits of quantitation of the methods were 100 ng/ml for total and 1.0 ng/ml for free CPT using 50 microl and 250 microl plasma, respectively. Special attention was paid to the stability of the analytes. The presented method was successfully applied in a clinical pharmacokinetic study in our institute.

MeSH terms

  • Antineoplastic Agents, Phytogenic / blood*
  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / pharmacokinetics
  • Calibration
  • Camptothecin / blood*
  • Camptothecin / chemistry
  • Camptothecin / pharmacokinetics
  • Chromatography, High Pressure Liquid / methods*
  • Humans
  • Polymers
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Antineoplastic Agents, Phytogenic
  • Polymers
  • Camptothecin